Pfizer (PFE) Stops Phase 3 Trial of Sutent in Metastatic Colorectal Cancer
Tweet Send to a Friend
Pfizer Inc. (NYSE: PFE) announced today the discontinuation of the SUN 1122 Phase 3 trial that ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
